ArticleOncoimmunology2016
Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells.
Pavel Otáhal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
58 papers cite it
this paperpooled ittrialcites it